Cogstate Limited (CGS)

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!

General Information
Company Name: Cogstate Limited
Stock Code: CGS
GICS Sub-Industry: Health Care Services
Market Cap ($M): 22
Equiv. Shares (M): 99

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.220 $ 0.000 $ 0.000 $ 0.000 $ 0.220 0 0%

Company Overview

Business Description:
Cogstate Ltd (CGS) is a multi-faceted cognitive assessment and training company focused on the development and commercialisation of rapid, computerised tests of cognition (brain function). The Company has four distinct business units, being Clinical Trials, Axon Sports, Healthcare and Cogstate Research with 5 primary offices in Australia, America and Spain.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014  A -3.9 -4.3 -- 0.0 0.0 0.0 --
2013  A -2.0 -2.6 -- 0.0 0.0 0.0 --
2012  A 2.5 3.3 -- 6.8 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Capitol Health (CAJ) $274 M 0.7872 -- -- 37.7976 -- -- 1.42 -- --
Cogstate (CGS) $22 M -- -- -- -- -- -- 0.00 -- --
Virtus Health (VRT) $588 M 1.2932 0.2014 0.1800 19.1268 15.9204 13.4922 3.53 3.90 4.60

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
CGS -- -- 1.67 -- 1.61
Market 1.16 13.8 1.03 1.05 3.00
Sector 0.70 19.6 2.43 1.55 2.36

Name Position Start Date
Mr Martyn Kenneth Myer Chairman 01 October 1999
Mr Bradley O'Connor Chief Executive Officer 01 December 2005
Mr David Darby Executive Director 22 November 2013
Mr David Alexander Simpson Non-Executive Director 24 August 2004
Mr Richard van den Broek Non-Executive Director 26 August 2010

Name Position
Paul Maruff Chief Scientific Officer
Claire Newstead-Sinclair Company Secretary
Roger O'Sullivan General Counsel
Sophie Egholm President Clinical Trials

Substantial Shareholders
Holding Name
7,472,928 (9.64%) Asia Union Investments Pty Ltd
15,714,044 (20.28%) National Nominees Limited
12,961,831 (16.73%) Quixote Investment, LLC

Calendar of Events
Date Event
18 September 2015 Report (Annual)
19 August 2015 Report (Annual)
19 August 2015 Report (Prelim)
18 February 2015 Report (Interim)
17 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at


Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Active Investing and Trading

An educational booklet with information on how analysis and risk management can enhance your share investments.

More details...


Prices slashed - everything must go!

Nick Swales, Regional Director, Newcastle Office, Rathbones 27/10/2014 | “If you want to have a better performance than the crowd, you must do things differently from the crowd.” Sir John Templeton.

Aussie share market bulls now have company

Ric Spooner (Chief Market Analyst, CMC Markets) 20/10/2014 | Today, Australian investors will not have to go it alone buying stocks as they did for much of last week. Bargain hunters this morning will be supported by the morale boosting encouragement of a 3% turnaround in the German Dax and a 264 point rally in the Dow Jones.

The Importance of Ignoring the Noise of the Market

Carl Richards, director of investor education at the BAM Alliance 17/10/2014 | “As odd as it may sound, the sooner you start treating your investments like you treat life, the happier you’ll be with the outcome.”

You only dance twice

William H. Gross, Janus Capital Group 16/10/2014 | “Financial markets are artificially priced. In the bond market, there is nothing normal about a three year German Bund yielding “minus” 10 basis points.”

The Big Picture - Australia 200 Index

CMC Markets 8/10/2014 | Share market indices around the globe are breaking down. While analysts cast around for reasons, it’s clear that a time factor is in play. Simply put, many investors “feel” a correction is overdue. How low could it go?

Billionaires bankroll Ten's new direction Media Network sees digital future

The Age 19/12/2013 | Ten Network's programming ambitions will be funded by a $200 million loan guaranteed by three of its billionaire owners, as the free-to-air broadcaster declared digital was the future and pointed to early signs that its switch to an older market demographic was working.


Sponsored Links